跳至主要内容
临床试验/NCT07759518
NCT07759518已完成不适用

Letrozole High Dose (10 mg) Compared to Letrozole Low Dose( 5 mg) for Ovarian Stimulation in Infertile Women With Polycystic Ovary Syndrome

Mst.Sumyara Khatun1 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2025年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
86
试验地点
1
主要终点
Presence of preovulatory follicle

研究概览

简要总结

The goal of this clinical trial is to learn if drug letrozole 10mg for 5 days works better than letrozole 5mg for 5 days for ovarian stimulation in infertile women with PCOS. It will also learn about the safety of drug letrozole . The main questions it aims to answer are:

What medical problems do participants have when taking drug letrozole? Researchers will compare drug letrozole 10mg for 5 days works better than letrozole 5 mg for 5 days for ovarian stimulation in infertile women with PCOS

Participants will:

The experimental arm (p1) will be treated with letrozole 10 mg for 5 days. The comparator arm (p2) will receive letrozole 5 mg for 5 days for ovulation induction for consecutive 3 months Treatment will start from the 2nd day of menstruation cycle or withdrawal bleeding after the baseline visit and investigations.

Ovarian response will be assessed by trans-vaginal monitoring of follicle growth around day 10 of menstrual cycle

详细描述

Atotal number of 86 eligible PCOS women will be randomized to either letrozole 10 mg for 5 days or letrozole 5 mg for 5 days for ovulation induction. The experimental arm (p1) will be treated with letrozole 10 mg for 5 days. The comparator arm (p2) will receive letrozole 5 mg for 5 days (Tab letrol 2.5mg -Renata Pharmaceutical. Treatment will start from the 2nd day of menstruation cycle or withdrawal bleeding after the baseline visit and investigations.

Ovarian response will be assessed by trans-vaginal monitoring of follicle growth around day 10 of menstrual cycle.The presence of preovulatory follicle, multifollicular development, the number of developing follicles, size of largest follicle and endometrial thickness with pattern will be assessed. The woman will then be advised to test for LH surge by urinary LH kit daily until positive and when positive will have intercourse for two days. She will have serum progesterone estimation after 7 days. She will repeat same dose of ovulation induction if she has menstruation and if there are no symptoms of side effect regarding letrozole intake or will do pregnancy test if she misses period. If missed period occurs further visit will be required for serum β-hCG estimation for confirmation of pregnancy. If pregnancy test is positive she will do an USG for fetal cardiac motion around 7-8 weeks.If B-hCG negative I will give the woman Tab. Norethisterone (5mg) (Tab. Normens 5mg - Renata pharmaceuticals) for (7-10) days for withdrawal bleeding. After withdrawal bleeding I will give her previous dose letrozole. In that situation she will define as a case of anovulation. If cyst appears I will do a Transvaginal sonography of that woman in D2 of the cycle to observe the cyst. If cyst persist, I will hold stimulation in that cycle. If cyst disappear I will give stimulation. All subject will receive drugs (Tab. Letrol 2.5mg, Tab. Normens 5mg) from me. I will ensure their proper intake by cell phone and during their visit they will show their blank strip of drug for confirmation. The cumulative data will be subjected to analysis. by Statistical Package for Social Sciences version 27 for Windows (SPSS Inc., Chicago, Illinois, USA).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Age: 18-35 years old
  • •BMI : 18-30 kg/m2
  • •Diagnosed cases of PCOS patients according to Rotterdam criteria.
  • •Corrected hypothyroidism and hyperprolactinemia

排除标准

  • •Women with other infertility factors (endometriosis, tubal and uterine causes of infertility)
  • •Male factor infertility
  • •Impaired hepatic or renal function
  • •History of hypersensitivity to letrozole

研究组 & 干预措施

Tab.Letrozole 10 mg for 5 days

Experimental

Tab letrozole 10 mg for 5 days from day 2-3 of menstruation/withdrawal bleeding (5mg at morning and 5mg bed time for 5 days) for 3 cycle

干预措施: Tab.Letrozole 10 mg for 5 days (Drug)

Tab.Letrozole 5 mg for 5 days

Active Comparator

Tab letrozole 5mg for 5 days from day 2-3 of enstruation/withdrawal bleeding ( 5mg at bed time for 5 days) for three cycle

干预措施: Tab.Letrozole 5mg for 5 days (Drug)

结局指标

主要结局

Presence of preovulatory follicle

时间窗: 12 weeks

Preovulatory follicle:A follicle14 mm or more

Multifollicular development

时间窗: 12 weeks

Multifollicular development: Presence of more than one preovulatory follicle

次要结局

  • Ovulation Rate(3 months)
  • Pregnancy rate(3 months)
  • Number of developing follicles(3 months)
  • Days to LH surge(3 months)

研究者

发起方
Mst.Sumyara Khatun
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Mst.Sumyara Khatun

Medical Officer

Bangladesh Medical University

研究点 (1)

Loading locations...

相似试验